Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. Zielonka (Warszawa, Poland), J. Bigaj (Bangor, United Kingdom), N. Czaicki (Ipswich, United Kingdom). Factors affecting vaccination rates against influenza in adults with asthma. 2408

Member's Comments

No comment yet.

Related content which might interest you: Seasonal influenza vaccination rates in chronic asthma patients Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 Seasonal influenza vaccination in Canadian adolescents with and without asthma. Source: International Congress 2019 – Asthma epidemiology in the 21st century Year: 2019 The importance of pneumococcal and influenza vaccines in patients with allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 376s Year: 2005 Impact vaccination against pneumococcal infection for clinical-functional indexes and course of bronchial asthma in children Source: Eur Respir J 2004; 24: Suppl. 48, 611s Year: 2004 Influenza A H1N1 as a risk for asthma in children Source: Annual Congress 2010 - Paediatric epidemiology: infection, prematurity and congenital abnormalities Year: 2010 Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Outcome of influenza vaccination in elderly with pneumonia Source: International Congress 2019 – Airway infection in COPD Year: 2019 Impact of influenza vaccination in patients with CAP Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Evolution of influenza vaccination coverages in Spanish patients with asthma or chronic bronchitis Source: Eur Respir J 2004; 24: Suppl. 48, 144s Year: 2004 Efficacy of influenza and pneumococcal vaccinations among patients with COPD Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Serotype dynamics in pneumococcal diseases and the performance of vaccination strategies for older adults in germany Source: Virtual Congress 2020 – How do different treatment strategies translate into costs Year: 2020 Societal perspective and challenges of influenza and pneumococcal vaccination in patients at risk of respiratory complications Source: Annual Congress 2008 - Why vaccinate patients with chronic respiratory conditions? Today and tomorrow's perspectives Year: 2008 Why are people with asthma more susceptible to influenza? Source: Eur Respir J, 54 (4) 1901748; 10.1183/13993003.01748-2019 Year: 2019 Correlation of regional death rates for asthma and influenza Source: Eur Respir J 2006; 28: Suppl. 50, 442s Year: 2006 Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Source: Eur Respir J 2004; 23: 363-368 Year: 2004 Factors affecting attitude towards pneumococcal and influenza vaccination in patients admitting to a pulmonary diseases outpatient clinic Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 Influenza A/H1N1v infection in Belgian children with and without underlying risk factor Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors Year: 2010 Prognostic factors for mortality in adults with pneumonia due to influenza A (H1N1) Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Vaccination rates against pneumococcal and influenza infection in hospitalized cardiologic and pneumologic patients need to be improved. Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer Year: 2018